Emmaus Medical

Developer of small molecule therapeutics for the treatment of sickle cell anemia and sickle ß0-thalassemia

placeTorrance, California, United States calendar_todayFounded 2000 groups44 employees language emmausmedical.com

Registered entities

Innovation

6 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 154 times.

YearFilings
20132
20142
20152
20161
20172
20182
20192
20202
20214
20223
20232
20241

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital117%
Private equity233%
Other / undisclosed350%
Coming soon